Quick Answer
Pediatrix Medical Group, Inc. reported Stockholders Equity of $865.85 million for fiscal year 2025.
Pediatrix Medical Group, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $865.85M | +13.2% |
| 2024 | $764.94M | -9.9% |
| 2023 | $849.06M | -4.8% |
| 2022 | $891.63M | -0.5% |
| 2021 | $896.49M | +19.9% |
| 2020 | $747.49M | -50.1% |
| 2019 | $1.50B | -51.5% |
| 2018 | $3.09B | +0.7% |
| 2017 | $3.07B | +11.1% |
| 2016 | $2.76B | +13.3% |
| 2015 | $2.44B | +7.6% |
| 2014 | $2.26B | -3.3% |
| 2013 | $2.34B | +15.1% |
| 2012 | $2.04B | +17.6% |
| 2011 | $1.73B | +19.6% |
| 2010 | $1.45B | +21.6% |
| 2009 | $1.19B | +23.3% |
| 2008 | $965.14M | +0.6% |
| 2007 | $959.05M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $890.67M | +21.6% | +6.8% |
| June 30, 2025 | $833.75M | +18.0% | +5.6% |
| March 31, 2025 | $789.19M | -7.8% | +3.2% |
| December 31, 2024 | $764.94M | -9.9% | +4.4% |
| September 30, 2024 | $732.49M | -24.3% | +3.7% |
| June 30, 2024 | $706.46M | -25.0% | -17.5% |
| March 31, 2024 | $856.20M | -5.9% | +0.8% |
| December 31, 2023 | $849.06M | -4.8% | -12.3% |
- Pediatrix Medical Group, Inc. showed an increase of +13.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, Pediatrix Medical Group, Inc.’s stockholders equity has declined by 9.7% (from $959.05 million to $865.85 million).
- The most recent figure is from Pediatrix Medical Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: